Khodabandeh Behzad, Shafiee Erfan, Farzad Maryam, Smaeel Beygi Amirreza
Occupational Therapy Department, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
School of Physical Therapy, Department of Health and Rehabilitation Sciences, University of Western Ontario, Canada.
Arch Bone Jt Surg. 2022 Feb;10(2):213-218. doi: 10.22038/ABJS.2021.53348.2647.
The Identification Pain questionnaire (IDPQ) is one of the recommended tools by the Neuropathic Pain Special Interest Group of the International Association for the Study of Pain for neuropathic pain screening. This study aimed to translate, cross-culturally adapt, and validate the Persian version of the IDPQ.
First, the IDPQ was translated based on the recommended guidelines. Afterward, the internal consistency (Cronbach's alpha coefficient), test-retest reliability (intraclass correlation coefficient), construct validity (compared to the Douleur Neuropathique 4 [DN4] questionnaire), and discriminant validity (Receiver operating curve analysis) of the IDPQ-P were evaluated. A total of 90 patients with neuropathic (n=50) and nociceptive pain (n=40) were enrolled in the study. In the next 72 h after the initial assessment, 30 patients (15 with neuropathic and 15 with nociceptive pain) completed the IDPQ-P.
No modifications were needed in the process of translation and cultural adaptation. Cronbach's alpha coefficient was obtained at 0.47 for all patients, indicating poor internal consistency. The intraclass correlation coefficient was estimated at 0.97, showing excellent test-retest reliability. A high correlation was found between the DN4 questionnaire and IDPQ-P (0.74), showing acceptable construct validity. The area under the curve was 0.94 (95% CI: 0.88-0.99) and 0.92 (95% CI: 0.85-0.99) when the physician's diagnosis and the DN4 cut-off value were used as the reference standard, respectively. The optimal cut-off value of ≥ 2 demonstrated the highest sensitivity (98%) and specificity (79%).
The IDPQ-P can be used in the clinical setting as an accurate and quick screening tool to diagnose patients with neuropathic pain. Sufficient test-retest reliability, construct validity, discriminant validity, and high diagnostic accuracy were found for the IDPQ-P.
识别疼痛问卷(IDPQ)是国际疼痛研究协会神经病理性疼痛特别兴趣小组推荐的用于神经病理性疼痛筛查的工具之一。本研究旨在翻译、跨文化适应并验证IDPQ的波斯语版本。
首先,根据推荐指南对IDPQ进行翻译。随后,评估IDPQ-P的内部一致性(Cronbach'sα系数)、重测信度(组内相关系数)、结构效度(与神经病理性疼痛4[DN4]问卷比较)和区分效度(受试者操作特征曲线分析)。共有90例神经病理性疼痛患者(n = 50)和伤害性疼痛患者(n = 40)纳入研究。在初始评估后的接下来72小时内,30例患者(15例神经病理性疼痛患者和15例伤害性疼痛患者)完成了IDPQ-P。
在翻译和文化适应过程中无需修改。所有患者的Cronbach'sα系数为0.47,表明内部一致性较差。组内相关系数估计为0.97,显示出出色的重测信度。发现DN4问卷与IDPQ-P之间存在高度相关性(0.74),表明结构效度可接受。当以医生诊断和DN4临界值作为参考标准时,曲线下面积分别为0.94(95%CI:0.88 - 0.99)和0.92(95%CI:0.85 - 0.99)。≥2的最佳临界值显示出最高的敏感性(98%)和特异性(79%)。
IDPQ-P可在临床环境中用作诊断神经病理性疼痛患者的准确、快速筛查工具。IDPQ-P具有足够的重测信度、结构效度、区分效度和高诊断准确性。